Significance of bone marrow fibrosis in multiple myeloma

Pathology

Volumn 39, Issue 5, 2007, Pages 512-515

  Subramanian, Rajiv ^a   Basu, Debdatta ^a   Dutta, Tarun K ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Bone marrow; Marrow fibrosis; Multiple myeloma

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MITOSIS; MULTIPLE MYELOMA; MYELOFIBROSIS; PLASMA CELL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

ADULT; AGED; BIOPSY; BONE MARROW EXAMINATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYELOFIBROSIS; PROGNOSIS;

EID: 34548863957     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020701570038     Document Type: Article

References (12)

1. Sachdev R, Singhal N, Singh T, Singh ZN. Marrow fibrosis in multiple myeloma - a case report. Ind J Hematol Blood Transfus 2003; 21: 92-3.
2. Vandermolen L, Rice L, Lynch EC. Plasma cell dyscrasia with marrow fibrosis. Clinicopathologic syndrome. Am J Med 1985; 79: 297-302.
3. McCarthy DM. Fibrosis of the bone marrow: content and causes. Br J Haematol 1985; 59: 1-7.
4. Peest D, Coldewey R, Deicher H, Sailer M, Vykoupil C, Leo R. Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: improved definition of risk groups. Eur J Cancer 1993; 29A: 978-83.
5. Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005; 90: 1128-32.
6. Krzyzaniak RL, Buss DH, Cooper MR, Wells HB. Marrow fibrosis and multiple myeloma. Am J Clin Pathol 1988; 89: 63-8.
7. Pich A, Chiusa L, Marmont F, Navone R. Risk groups of myeloma patients by histologic pattern and proliferative activity. Am J Surg Pathol 1997; 21: 339-47.
8. Sailer M, Vykoupil KF, Peest D, Coldewey R, Deicher H, Georgii A. Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: a histopathological evaluation of biopsies from 153 untreated patients. Eur J Haematol 1995; 54: 137-46.
9. Sukpanichnant S, Cousar JB, Leelasiri A, Graber SE, Greer JP, Collins RD. Diagnostic criteria and histologic grading in multiple myeloma: histologic and immunohistologic analysis of 176 cases with clinical correlation. Hum Pathol 1994; 25: 308-18.
10. Ng AP, Wei A, Bhurani D, Chapple P, Feleppa F, Juneja S. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells. Haematologica 2006; 91: 972-5.
11. Terpstra WE, Lokhorst HM, Blomjous F, Meuwissen OJ, Dekker AW. Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma. Br J Haematol 1992; 82: 46-9.
12. Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jaeger K, Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am J Clin Pathol 1987; 87: 342-55.